Assessing Quality of Life Post-Breast Reconstruction Surgery: Findings from an Interim Analysis of the REKO 001 Three-Arm Clinical Trial with a Decade of Follow-Up - Takeaways - MDSpire

Assessing Quality of Life Post-Breast Reconstruction Surgery: Findings from an Interim Analysis of the REKO 001 Three-Arm Clinical Trial with a Decade of Follow-Up

  • By

  • B. Boeer

  • J. Kandzi

  • B. Schoenfisch

  • M. Marx

  • S. Guergan

  • I. Gruber

  • C. Roehm

  • G. Helms

  • A. Hartkopf

  • S. Y. Brucker

  • M. Hahn

  • April 7, 2026

  • 0 min

Share

  • 1

    Patients undergoing autologous reconstruction (DIEP/FCI) show improved quality of life after five months despite higher complication rates.

  • 2

    The REKO 001 trial compares quality of life outcomes among mastectomy, implant-based, and autologous reconstruction over a decade.

  • 3

    Health-related quality of life (HRQoL) is a crucial factor influencing patient satisfaction and survival in breast cancer.

  • 4

    The study utilized BREAST-Q and FACT-B questionnaires to assess psychosocial, sexual, and physical outcomes post-surgery.

  • 5

    A total of 234 patients were enrolled, with 204 completing the HRQoL assessment five months post-surgery.

Original Source(s)

Assessing Quality of Life Post-Breast Reconstruction Surgery: Findings from an Interim Analysis of the REKO 001 Three-Arm Clinical Trial with a Decade of Follow-Up

  • by B. Boeer, J. Kandzi, B. Schoenfisch, M. Marx, S. Guergan, I. Gruber, C. Roehm, G. Helms, A. Hartkopf, S. Y. Brucker, M. Hahn

  • April 7, 2026

Related Content

Insulin-like growth factor 1 receptor regulates breast cancer cell adhesion through beta-1 integrin

Clinical implications of 10-formyltetrahydrofolate dehydrogenase expression in hormone receptor-positive breast cancer

Dynamic changes and clinical significance of the gut microbiota and serum metabolites in breast cancer onset, progression and chemotherapy intervention